Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Are sirolimus-eluting stents superior to paclitaxel-eluting stents in patients with small-vessel disease?

Nature Clinical Practice Cardiovascular Medicine volume 5, pages 188–189 (2008)Cite this article

boxed-textTogni M et al. (2007) Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. J Am Coll Cardiol 50: 1123–1131

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Daemen J and Serruys PW (2007) Drug-eluting stent update 2007: part I. A survey of current and future generation drug-eluting stents: meaningful advances or more of the same? Circulation 116: 316–328

    Article  Google Scholar 

  2. Stettler C et al. (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370: 937–948

    Article  CAS  Google Scholar 

  3. Kastrati A and Schömig A (2007) Drug-eluting stents: is their future as bright as their past? J Am Coll Cardiol 50: 146–148

    Article  Google Scholar 

  4. Kastrati A et al. (2006) Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 113: 2293–2300

    Article  Google Scholar 

  5. Mehilli J et al. for the Intracoronary Drug-Eluting Stenting to Abrogate Restenosis in Small Arteries (ISAR-SMART 3) Study Investigators (2006) Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J 27: 260–266

    Article  CAS  Google Scholar 

  6. Rogers C and Edelman ER (2006) Pushing drug-eluting stents into uncharted territory: simpler than you think—more complex than you imagine. Circulation 113: 2262–2265

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. A Kastrati is Professor of Cardiology and A Schömig is Professor of Medicine, and both are Interventional Cardiologists, at the Deutsches Herzzentrum, Technische Universität München, Germany.,

    Adnan Kastrati & Albert Schömig

Authors
  1. Adnan Kastrati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Albert Schömig
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Albert Schömig.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kastrati, A., Schömig, A. Are sirolimus-eluting stents superior to paclitaxel-eluting stents in patients with small-vessel disease?. Nat Rev Cardiol 5, 188–189 (2008). https://doi.org/10.1038/ncpcardio1120

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio1120

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing